Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen

J. L. Murray, M. G. Rosenblum, L. Lamki, T. P. Haynie, H. J. Glenn, C. E. Plager, M. W. Unger, D. J. Carlo, E. M. Hersh

Research output: Contribution to journalArticle

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)3-9
Number of pages7
JournalNCI Monographs
VolumeNo. 3
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen'. Together they form a unique fingerprint.

  • Cite this

    Murray, J. L., Rosenblum, M. G., Lamki, L., Haynie, T. P., Glenn, H. J., Plager, C. E., Unger, M. W., Carlo, D. J., & Hersh, E. M. (1987). Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen. NCI Monographs, No. 3, 3-9.